FDA Investigator Gloria J Baca, MS
Gloria J Baca, MS has conducted inspections on 133 sites in 5 countries as of 08 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
133
Last Inspection Date:
08 May 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
India,
Czechia,
Bulgaria,
Germany
FDA Investigators that have inspected at least one site in common with Gloria J Baca, MS:
Aaron J Poloni,
Alexander M Kay,
Amber M Howell,
Andrew K Haack, PhD,
Anita Narula, PhD,
Ashar P Parikh,
Ashleigh P Barkans,
Astrida B Mattson,
Ava M Bowman,
Barbara J Rincon,
Barbara Janine Breithaupt,
Beau R Lamb,
Bo Chi, PhD,
Bradley Dworak, PhD,
Bruce R Burrell,
Bryan Baker,
Bryce A May,
Bryce E Mansfield,
Carl A Anderson,
Caryn M Mcnab,
Catherine J Laufmann,
Celeta S Coves,
Celia L Hutchinstein,
Celia L Silverstein,
Chiaochun J Wang,
Christian D Lynch (CDL),
Christina L Norton,
Christine A Harman, PhD,
Christopher R Czajka,
Connie P Rezendes,
Courtney R Ingalsbe,
Crystal A Harlan,
Crystal Monroy,
Cynthia J Lee, MS,
Cynthia L Gorveatt,
Dan G Eisenbrey,
Dawn E Barkans,
Deborah A Nebenzahl,
Deborah Kleinfeld,
Dennis G Kawabata,
Dennis R Hudson,
Devon M Shoop,
Dianna D Wardlow Dotter,
Dolores E Price,
Don H Bark, PhD,
Donald B Mckechnie,
Donald C Obenhuber, PhD,
Donald W Jehn,
Edward D Harris,
Edwin Melendez,
Eileen A Liu,
Elizabeth S Howell,
Erica D Butler,
Garrad R Poole,
George Lunn, PhD,
Gerard Pde Leon,
Gina C Collins,
Gloria A Milster,
Gordon T Wales,
Harmon M Blanch,
Heika R Bounds,
Heika R Tait,
Hugh A Grimoldby,
Huiquan Wu,
Hung H Do, MS,
Ian J Thomson,
Jacqueline Mdiaz Albertini,
James C Henry,
James D Hildreth,
Jane M Kreis,
Janete F Guardia,
Jason T Lovelady,
Jean Brewer,
Jeffrey J Leclair,
Jennifer L Bridgewater,
Jessica L Walters Moell,
Jinkee Mvila Binayug,
Joan M Cantellops Figueroa,
Joey V Quitania,
John A Gonzalez,
John A Iwen,
John E Emmert,
Jonathan T Little,
Julian C Hanson,
Kaarin M Slotte,
Kari M Johansen,
Katherine L Arnold,
Kathryn A Krentz,
Keegan B Mixon,
Kelly D Moore,
Kelsey M Bishop,
Kenneth O Gee, PhD,
Khoa Nathanv Tran,
Kimberly A Dux,
Kip J Hanks,
Ko U Min,
Kristin M Abaonza,
Kristina M Phelps,
Kristopher J Stanya, PhD,
Kurt M Hafer,
Larry K Austin,
Laura E Hausch,
Laurel A Beer,
Lauren E Swantko,
Lawrence Y Lee, PhD,
LCDR Debra Emerson,
LCDR Ismael Olvera, IV,
Lee Terry Moore,
Leonard H Lavi,
Liming Zhang,
Linan Ha, PhD,
Linda F Murphy,
Linda S Leja,
Linh Tu,
Lisa A Bowden,
Lisa K Capron,
Lisa M Althar,
Lisa Shin,
Lori J Silverstein,
Lorna F Jones,
LTJG Bradley E Benasutti,
Lynda L Perry, PhD,
Mai Hang,
Marc A Jackson, Jr,
Maria Pkelly Doggett, MBA,
Marijo B Kambere, PhD,
Mariza M Jafary,
Marjorie A Shapiro, PhD,
Mark L Collins,
Mark W Babbitt,
Marlene L Davis,
Marsha L Mccauley,
Maxine H Wong,
Michael J Donovan,
Michael J Lackey,
Michael S Hudson,
Mihaly S Ligmond,
Mikel T Wright,
Nancy A Saxenian Emmons,
Nancy E Byerly,
Nancy E Doyle,
Nataniel Phillips Sylvain, PhD,
Neil J Traaen,
Nicholas L Hunt,
Nicole M Bell,
Omotunde O Osunsanmi,
Paul F Rader,
Paul M Chefor,
Paula A Trost,
Paula J Wilkerson,
Peter Kessler, PhD,
Peter T Regan,
Philip F Istafanos, DMV, MS,
Philippe A Cornet,
Prabhu P Raju,
Randy L Self,
Rebecca Rodriguez,
Rebecca T Davis,
Richard T Riggie,
Robert B Shibuya, MD,
Robert D Tollefsen,
Rocco C Black,
Ronald E Gill,
Ryan J Lubert,
S Lori Brown, PhD MPH,
Sangeeta M Khurana, PhD,
Sangeeta M Rataul,
Sarah J Cullen,
Scott A Nabe,
Scott B Laufenberg,
Sharon L Shane,
Shelagh D Schopen,
Shelley H Beausoleil,
Sherri N Rohlf, MD,
Sridhar Thumma,
Sripal R Mada, PhD,
Stacy A Schneider,
Stanley B Eugene, BS, BME,
Stephanie A Jameson,
Stephen R Souza,
Sunitha K Rajaram, PhD,
Susan F Laska, MS,
Terri L Dodds,
Thomas C Mclean, CFS,
Thomas J Arista,
Timothy D Evans,
Timothy S Williamson,
Tina S Roecklein,
Tracy K Li,
Uttaniti Limchumroon (Tom),
V Teres Speer,
Vanessa Y Gelsey, PhD,
Vanessa Y Jacobs,
Victoria V Bot,
Vitaliy N Guyvan,
Xikui Chen (nmi), PhD,
Xiomara Copeland,
Young M Yoon,
Zachary A Bogorad,
Zachary L Miller,
Zachary P Wachlarowicz
Gloria J Baca, MS's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more